These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 25029134

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is vasopressin increasing or decreasing mortality in patients with septic shock?
    Rehberg S, Ertmer C, Van Aken H, Westphal M.
    Surg Infect (Larchmt); 2008 Apr; 9(2):215 author reply 216. PubMed ID: 18426355
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 5. Vasopressin in septic shock.
    Russell JA.
    Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417
    [No Abstract] [Full Text] [Related]

  • 6. Vasopressin for vasopressor-dependent septic shock.
    Szumita PM, Enfanto CM, Greenwood B, Wechsler ME.
    Am J Health Syst Pharm; 2005 Sep 15; 62(18):1931-6. PubMed ID: 16141113
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA.
    Shock; 2010 Apr 15; 33(4):375-80. PubMed ID: 19851126
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY, Stollings JL, Wheeler AP, Semler MW, Rice TW.
    Ann Pharmacother; 2017 Jan 15; 51(1):13-20. PubMed ID: 27630192
    [Abstract] [Full Text] [Related]

  • 10. Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
    Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M.
    Am J Respir Crit Care Med; 2016 Sep 01; 194(5):550-8. PubMed ID: 27398737
    [Abstract] [Full Text] [Related]

  • 11. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
    Saad AF, Maybauer MO.
    J Crit Care; 2017 Aug 01; 40():41-45. PubMed ID: 28319910
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exogenous Vasopressin-Induced Hyponatremia in Patients With Vasodilatory Shock: Two Case Reports and Literature Review.
    Salazar M, Hu BB, Vazquez J, Wintz RL, Varon J.
    J Intensive Care Med; 2015 Jul 01; 30(5):253-8. PubMed ID: 24106070
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis.
    Bunker N, Higgins D.
    Crit Care Med; 2006 Mar 01; 34(3):935; author reply 935-6. PubMed ID: 16505698
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis.
    Stolk RF, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden AE, Gerretsen J, Schambergen R, Ruth MM, van der Hoeven JG, van Leeuwen H, Pickkers P, Kox M.
    Am J Respir Crit Care Med; 2020 Sep 15; 202(6):830-842. PubMed ID: 32520577
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.